baber/WOPTO huggingface dataset:
Patent ES-543826-A0 (ES)
IPC: A61K9/54
Filed: 1985-06-03
Abstract: A pharmaceutical composition of a medicament, such as a 5-(pyridinyl)-2(IH) pyridone, in sustained release unit dosage form for oral administration. The composition is in the form of beads within a capsule of gelatin or the like. Each bead comprises an inert particulate core having adhered thereto a coating of particles of the medicament. This coating is in turn surrounded by a sustaining coating of three different polymers with different solubility profiles to allow a sustained release of the medicament both in the low pH environment of the stomach and at a higher pH values prevailing in the intestine.
Patent ES-550106-A0 (ES)
IPC: C07D405/12
Filed: 1985-12-18
Abstract: The invention relates to a group of new bicyclic heter- oarylpiperazine derivatives which can be used as starting materials for the preparation of other compounds. Moreover, some of the compounds have interesting blood-pressure lowering activity.The compounds can be prepared according to methods known for the preparation of analogous compounds.
Patent FI-843806-A0 (FI)
Inventor: MICHIELS DIRK JOSEF MARIA
IPC: B05D1/26
Filed: 1984-09-27
Abstract: Extrusion coating with high line speeds of up to 600 mpm may be achieved without sacrificing the adhesion of the coating to the substrate by using an ethylene copolymer with up to 3% by weight copolymer, preferably 0.5 to 2.5% by weight VA, as the coating polymer. The extrusion temperature is in the region of incipient degradation, but maintained below the level which gives undesirable degradation leading to odour or disciouration.
Patent FI-850051-A0 (FI)
Inventor: SEELIG RENATE
IPC: C12N7/02
Filed: 1985-01-04
Abstract: The invention relates to a process for obtaining a virus, respectively a virus antigen from biological material, particularly from body liquids, whereby fibronectine to which the virus is bound is extracted; to this effect, as a starting material will be used either a body liquid containing already fibronectine or a biological starting material to which fibronectine has been previously added; after isolating the fibronectine to which the virus is bound, the virus, respectively the viral antigen is obtained in a free state by breakage of the bond with the fibronectine; this release of the virus may be carried out according to a known process, particularly by specific enzyme action and/or surfactant action or by elimination reactions or simply by heating; as a result, a suspension is obtained from which the virus respectively the viral antigen may be isolated; the latter may be further purified in a manner known per se. The virus, respectively the viral antigen thus obtained, - and this concerns particularly the virus of hepatitis non A-non B -, is one aspect of the invention; however, the field of the invention extends also to the utilisation of the viral antigen obtained for the preparation of corresponding antibodies, to the field of immunologic diagnostic of hepatitis non A-non B and to the field of the preparation of vaccines. Furthermore, the invention also relates to a diagnostic kit enabling to diagnose the virus, respectively the viral antigenic material masked by the presence of unbroken or broken up fibronectine.
Patent FI-865220-A0 (FI)
Inventor: BONDINELL WILLIAM EDWARD
IPC: C07D223/16
Filed: 1986-12-19
Abstract: Compounds of the formula (1) : 
<CHEM>
 and pharmaceutically acceptable acid addition salts are described wherein R is hydrogen, or C1-C6alkyl or C3-C5alkenyl; R<1> is SOR<3>, SO2R<3> or SO2NR<4>R<5>; R<2> is hydrogen, C1-C6alkyl or R<6>O-; R<3> is C1-C6alkyl or trifluoromethyl; R<4> and R<5> are hydrogen or C1-C6alkyl; and R<6> is hydrogen, C1-C6alkyl or C1-C6alkanoyl, provided that when R<1> is SO2NH2, R<2> is R<6>O- or C1-C6alkyl. These compounds are useful in the treatment of gastrointestinal motility disorders. Pharmaceutical compositions and methods of use are described. Intermediates and processes for the preparation of compounds of the formula (1) are described.
Patent FI-873244-A0 (FI)
Inventor: MCGUIRE JOHN FINBARR
IPC: G07F7/08
Filed: 1987-07-24
Abstract: A point-of-sale credit card verifier (1) for checking the validity of cards, such as credit cards, comprises means for non-destructively storing information (3) on invalid credit cards for comparison with information which is read from a card presented for use. The information on invalid credit cards is transmitted by signals embedded in a VHF stereo radio broadcast from a broadcast station which is received by a VHF receiver/demodulator (10). A credit card sensor (4) and control maintains the verifier switched off unless a credit card is to be read. The verifier is switched on when information is about to be broadcast from a broadcast station. The verifier operates quickly and independently of telecommunications networks.
Patent FI-884683-A0 (FI)
Inventor: COCCIA MARIO
IPC: A61J1/00
Filed: 1988-10-12
Abstract: The invention relates to an apparatus for connecting a bottle (11) containing a medicament to a syringe (5) the needle (6) of which is housed in a closed chamber (7) defined by the apparatus and from which the needle (6) can be made to emerge by sliding the separate constituent parts (1, 2, 3) of the apparatus along each other. To prevent the needle (6) emerging from said chamber (7) when no bottle (11) is housed in the appropriate seat provided in the apparatus, there extends from one of the parts (1, 2, 3) of the apparatus an elongated flexible appendix (12) having at least one protuberance (13) which projects into said seat and against which the bottle (11) presses when inserted into the seat, so bending the appendix (12) outwards. In front of the free end of the appendix (12) there is provided a stop tooth (14) projecting from that constituent part (3) of the apparatus which is mobile along the first stated part (1) and extends totally around said seat. When no bottle (11) is inserted into the seat in the apparatus it is impossible to move the various parts (1, 2, 3) of the apparatus along each other because the free end of the flexible appendix (12) makes contact with and halts against said stop tooth (14), to thus prevent the needle (6) emerging from said chamber (7).
Patent FI-924710-A0 (FI)
Inventor: MARSCHALL ROBERT
IPC: C07K14/805
Filed: 1992-10-16
Abstract: PCT No. PCT/SE91/00221 Sec. 371 Date Dec. 15, 1993 Sec. 102(e) Date Dec. 15, 1993 PCT Filed Mar. 21, 1991 PCT Pub. No. WO91/16352 PCT Pub. Date Oct. 31, 1991.A pyridoxylated hemoglobin is prepared in a one-step, one-container process from red blood cells or essentially stroma-free hemoglobin by suspending the cells or hemoglobin in an aqueous medium, adding a chemical reducing agent and a pyridoxylating agent, and heating the reaction mixture obtained at a certain temperature for a certain time, while maintaining reducing conditions in the reaction medium.
Patent FI-934433-A0 (FI)
Inventor: GRAHN BENGT
IPC: E04H15/14
Filed: 1993-10-08
Abstract: PCT No. PCT/SE92/00208 Sec. 371 Date Dec. 30, 1994 Sec. 102(e) Date Dec. 30, 1994 PCT Filed Apr. 2, 1992 PCT Pub. No. WO92/18728 PCT Pub. Date Oct. 29, 1992A ventilation device for tents with at least one roof top (8) and a place for an open fire under this roof top, the tent cloth (4) having an upper boundary (12) at a distance below the apex of this roof top, so that an opening (9) for discharging flue gases coming from a fire is formed at the roof top, comprises a net (10) substantially impervious to insects, which is arranged in said flue gas opening (9) so as to prevent insects from getting into the tent through this opening. The insects net is movably arranged with respect to the frame work of the tent and the device further comprises an arrangement (14, 15, 18) for regulating the degree of the coverage of the flue gas opening by the insects net between a first position substantially entirely covering it and at least a position in which the flue gas opening is at least partially set free.
Patent FI-945416-A0 (FI)
Inventor: HAUPT ANDREAS
IPC: A61P35/00
Filed: 1994-11-17
Abstract: Novel derivates of dolastatin of formula (I) in which R<1>, R<2>, A, B, D, E, F, G, K, X, t, u, v, and w have the meanings stated in the description, and the preparation thereof are described. The novel substances have an antineoplastic effect.
Patent FI-952067-A0 (FI)
Inventor: WILLINGHAM JOHN DENIS
IPC: B65D5/02
Filed: 1995-04-28
Abstract: PCT No. PCT/GB93/02222 Sec. 371 Date Jun. 30, 1995 Sec. 102(e) Date Jun. 30, 1995 PCT Filed Oct. 28, 1993 PCT Pub. No. WO94/10081 PCT Pub. Date May 11, 1994A negative pressure dispense system comprises a dispense assembly to be fitted to a drum or other fluid container, and a coupling head to mate with the dispense assembly. The dispense assembly has an air valve to control the ingress of air to the fluid container and a fluid valve to control the egress of fluid from the fluid container. The coupling head seals solely with and opens the fluid valve. The dispense assembly and coupling head have complementary mating features that inter-engage upon relative mating movement between the dispense assembly and the coupling head. The dispense assembly fluid valve has a rotatable valve member, the coupling head has a part shaped to engage the rotatable valve member, and the dispense assembly and coupling head mating features inter-engage upon relative rotation whereby, in use, as the coupling head is rotated in the dispense assembly the mating features engage and the coupling head part engages and rotates the rotatable valve member to open the fluid valve.
Patent FI-962349-A0 (FI)
Inventor: WOLFMAN NEIL M
IPC: C12N15/09
Filed: 1996-06-06
Abstract: DNA molecules encoding mutant forms of bone morphogenetic proteins (BMP) are disclosed, The mutant forms of BMP can be produced bacterially and refolded to produce biologically active homodimers or heterodimers of BMP. A method of making such mutant BMPs is also disclosed.
Patent FI-982855-A0 (FI)
Inventor: PUUSKARI MIKKO
IPC: H04W36/12
Filed: 1998-12-31
Abstract: The invention relates to controlling selection of a gateway support node of a packet-switched network. The invention includes defining at least one condition for the gateway support node. When the condition is fulfilled, another gateway support node is more suitable for transmitting packets. When fulfillment of the condition is detected, a first message indicating the other gateway support node is transmitted to the serving support node.
Patent IL-57335-A0 (IL)
Title: N-aralkyl-substituted cyclic amines,their manufacture and their use as fungicides
IPC: C07D279/12
Filed: 1979-05-18
Abstract: New N-arylpropyl-substituted amines, and salts, molecular compounds and adducts thereof, having a good fungicidal action, fungicides containing these compounds, and processes for manufacturing these compounds.
Patent IL-58662-A0 (IL)
Title: Process for the preparation of unsaturated ethers
IPC: C07C41/16
Filed: 1979-11-07
Abstract: Unsaturated ethers of diphenols are prepared from alkenyl halides and diphenols as reagents and by carrying out the reaction in two zones at different temperatures. Intermediates for perfumes, aromas and insecticides are so prepared.
Patent IL-69340-A0 (IL)
Title: Phenothiazine derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07C217/62
Filed: 1983-07-26
Abstract: Substituted (10H-phenothiazin-10-yl)propyl-1-piperazines of the formula    <IMAGE>  I  wherein R1, R2, R3, A, X, m, n and s are as hereinafter set forth, are described. The compounds of formula I, which contain a piperazine moiety combined by an ether linkage to different phenolic moieties, are useful as orally active long lasting antipsychotic agents.
Patent IL-78399-A0 (IL)
Title: Slider units for sliding gate valves
IPC: H04Q3/62
Filed: 1986-03-31
Abstract: When a telephone subscriber receives a special dialling tone, special features are activated for his connection. In order to find out what features these are, or for what reason the special dialling tone is switched on, the subscriber, by dialling a particular code number or by outputting a special character by means of a key, can achieve a connection transmission to which an announcement device is connected. During this process, the special features activated for the subscriber connection identified during this process are transmitted in coded form from the central control of the connection transmission and thus the announcement device. Using these data, the announcement device assembles announcement texts which are spoken to the subscriber and contain all the information on activated special features. <IMAGE>
Patent IL-88270-A0 (IL)
Title: Fluorinated arachidonic acid derivatives
IPC: A61P37/08
Filed: 1988-11-03
Abstract: Fluorinated arachidonic derivatives are 5-lipoxygenase inhibitors which have the useful pharmacologic activity as antiallergy and anti-inflammatory agents and are useful for treating, for example, asthma, anaphylaxis, allergy, rheumatoid arthritis, and psoriasis.
Patent IL-96354-A0 (IL)
Title: Carbonyl stabilizers for 3-isothiazolones
IPC: A01N43/80
Filed: 1990-11-15
Abstract: A microbicidal composition is disclosed comprising     a) at least one 3-isothiazolone of the formula (I) <CHEM>  wherein Y is (C1-C18)alkyl or (C3-C12)cycloalkyl each optionally substituted with one or more of hydroxy, halo, cyano, alkylamino, dialkylamine, arylamino, carboxy, carbalkoxy, alkoxy, aryloxy, alkylthio, arylthio, haloalkoxy, cycloalkylamino, carbamoxy, or isothiazolonyl; an unsubstituted or halo-substituted (C2-C8) alkenyl or alkynyl; a (C7-C10)aralkyl optionally substituted with one or more of halogen, (C1-C4)alkyl or (C1-C4)alkoxy; and an aryl optionally substituted with one or more of halogen, nitro, (C1-C4)alkyl, (C1-C4)alkyl-acylamino, carb(C1-C4)alkoxy or sulfamyl; and  R and R<1> is each independently H, halogen or (C1-C4) alkyl; and   b) a carbonyl compound comprising (C2-C6) aldehydes, (C7-C10) aromatic aldehydes or acids, (C2-C4) dialdehydes, (C1-C12) acids, (C2-C8) diacids, triacids or tetracids, (C3-C10)  alpha , beta unsaturated carbonyls, (C1-C6) haloamides of the formula <CHEM>  where R3 = phenyl or (C1-C4)alkyl-substituted phenyl, R2 = (C1-C7)alkyl, (C1-C7)alkoxylalkyl, or (C1-C7)carbalkoxyalkyl, X1, X2, X3 = H or halogen wherein at least one X is halogen; or furfural, dibutylene furfural and maleimides of the formula <CHEM>  where R sec  is H, (C1-C4) alkyl or aryl; provided that when (b) comprises an aldehyde or dialdehyde the ratio (b):(a) is less than 10:1.   The carbonyl compound acts as a stabiliser for the 3-isothiazolone.
Patent IL-98969-A0 (IL)
Title: Cyclopentene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IPC: A61K31/357
Filed: 1991-07-26
Abstract: The invention relates to cyclopentane derivatives of formula (I) in which there is a double bond between the carbon atoms of centres a-b or b-c, and their salts with physiologically tolerable bases, and $g(a), $g(b) or $g(g)-cyclodextrin clathrates and the liposome-encapsulated compounds of formula (I), process of producing them and their pharmaceutical use.
Patent FI-20020500-A0 (FI)
Inventor: ORAVAINEN HEIKKI
IPC: B03D1/14
Filed: 2002-03-18
Abstract: The invention relates to a flotation arrangement (1, 15) for flotating minerals or the like from slurries containing these particles, said flotation arrangement comprising a flotation cell (3) including edges (2) and a bottm (10), and a mixing mechanism arranged in the flotation cell, elements for feeding air inot the cell and elements for feeding material to be flotated into the cell and for removing the flotated material out of the cell, so that in connection with the top edge (4) of the flotation cell (3) there is arranged at least one support element (6, 14) for facilitating the discharge of the foam layer (5) and for supporting the foam layer (5). In addition, the invention relates to a method for flotating minerals or the like from slurries containing these particles by means of a flotation arrangement (1, 15), said flotation arrangement comprising a flotation cell (3) including edges (2) and a bottom (10), and a mixing mechanism arranged in the flotation cell, elements for feeding air into the cell and elements for feeding material to be flotated into the cell and for removing the flotated material out of the cell, so that the foam layer (5) is supported and its removal is facilitated by at least one support element (6, 14) arranged in connection with the top edge (4) of the flotation cell (3).
Patent FI-20030943-A0 (FI)
Inventor: HUTTUNEN SAMPO
IPC: H04W4/70
Filed: 2003-06-25
Abstract: The invention relates to an M2M (machine-to-machine) module and to a method of configuring parameters of an M2M module, the method comprising establishing a connection between the M2M module and a server. The method comprises: downloading, to the M2M module, an application having an application programming interface (API) for configuring the M2M module, the application being configured to run on a Java virtual machine (JVM); communicating with the server by the application for receiving configuration parameters; and setting the parameters of the M2M module by the application based on the received configuration parameters.
Patent FI-20095916-A0 (FI)
Inventor: KLEEMOLA JAAKKO
IPC: F16N/
Filed: 2009-09-07
Abstract: The invention relates to a method for assessing the lubrication conditions of the mesh (17) between two gears (10, 12), in which gearbox (25) a shaft (11, 13) and bearings (14, 16, 15, 18) are attached to the said gears (10, 12), and in which method the resistance acting through the lubricant film in the gearbox (25) is measured by inducing a difference in voltage in the said gears (10, 12).  At least one of the said gears (10, 12) is insulated electrically from the casing (50) of the gearbox (25).
Patent IL-100112-A0 (IL)
Title: Microdelivery device and method for enhanced drug administration to the eye
IPC: A61F9/00
Filed: 1991-11-21
Abstract: A device (1) for pinpoint application of micro-quantities of a pharmacologically suitable composition to the outer hard coat of the eye, comprises a micro-container with a fixation element. The micro-container comprises a bore (5) whose aperture is adapted to contact the eye surface, and the fixation element is adapted for reversibly adhering to the eye surface.
Patent IL-103363-A0 (IL)
Title: Slow release polymeric drug delivery device
IPC: A61K9/22
Filed: 1992-10-06
Abstract: There is disclosed a slow release drug delivery device for the prolonged administration of topically active medicines which consists of a vehicle in which water is soluble and in which is dissolved the topically active drug which is formed into a stable organogel with a polymer matrix with a very low water absorbing capability. The organogel, in the presence of water or atmospheric water vapor, slowly imbibes such water into the vehicle and by doing so the vehicle becomes incompatible with the matrix and is slowly expelled therefrom. The vehicle dissolves the drug and the vehicle/drug combination is slowly pumped out of the polymeric matrix with substantially linear drug delivery occurring for periods in excess of 6 months. The drug delivery device may be used to administer drugs topically, as a collar or trans dermal patch, orally, as a slow delivery device, particularly as a ruminal bolus,, or as a suppository or a subcutaneous implant. The preferred form for the drug delivery device is as a flea and tick collar for household pets and the preferred active drug is selected from the avermectin and milbemycin families of active antiparasitic agents. <IMAGE>
Patent IL-106325-A0 (IL)
Title: Wire termination block
IPC: H01R4/24
Filed: 1993-07-13
Abstract: A printed circuit board mountable connecting block is provided with electrical contacts (26) which include an insulation displacement slot (34) at one end and a circuit mountable mounting tail (74) at the other end. This mounting tail may comprise a conventional solder mounting tail, or in a preferred embodiment, may comprise a "solderless" press-fit mounting tail, e.g. a resilient element. The connecting block may be mounted directly onto (e.g., through) a printed circuit board (57) (or other electronic component). <IMAGE>
Patent IL-122664-A0 (IL)
Title: Esters and amides as PLA2 inhibitors
IPC: C07D217/26
Filed: 1996-07-18
Abstract: The present invention relates to a novel fatty acid derivative of the following formula:  wherein R1 is acyl group; R2 is acyl(lower)alkyl; R3 is hydrogen, aryl(lower)alkyl, etc; R4 is acyl(lower)alkyl; and X is -O-,   [wherein R5 is lower alkyl, etc]; and a pharmaceutically acceptable salt thereof, which is useful as a medicament; the processes for the preparation of said fatty acid derivative or a salt thereof; a pharmaceutical composition comprising said fatty acid derivative or a pharmaceutically acceptable salt thereof; etc.
Patent IL-124798-A0 (IL)
Title: Bioactive load bearing bone bonding compositions
IPC: A61L31/00
Filed: 1996-12-06
Abstract: Novel fillers comprising combeite glass-ceramic are provided. hardenable restorative compositions comprising particulate combeite glass-ceramic provide improved biocompatibility in bone restorations. Hard, shaped bodies for orthopaedic, dental and other uses are also provided.
Patent IL-128012-A0 (IL)
Title: Text processor
IPC: G09B17/04
Filed: 1997-07-24
Abstract: A text enhancement method and apparatus for the presentation of text for improved human reading. The method includes extracting text specific attributes from machine readable text and varying the text presentation in accordance with the attributes. The preferred embodiment of the method: extracts parts of speech and punctuation from a sentence, applies folding rules which use the parts of speech to determine folding points, uses the folding points to divide the sentence into text segments, applies horizontal displacement rules to determine horizontal displacement for the text segments, and presents the text segments each on a new line and having the determined horizontal displacement. Another embodiment displays text color based on parts of speech.
Patent IL-132995-A0 (IL)
Title: Controlled comminution of materials in a whirl chamber
IPC: B02C19/00
Filed: 1998-05-22
Abstract: The invention describes a process of controlled comminution of a particulate solid material in to a milling having particles of predetermined dimensions, and also a milling whirl chamber having two end faces and a cylindrical side wall with at least one nozzle for injection a working fluid into the chamber, means for introducing the particulate solid material into the chamber, a central axial passage for discharge of the comminuted material in a flow of the working fluid from the chamber, and one or more mechanical elements for control of the comminution process in the chamber. The process includes tangential injection of the working fluid in to the chamber, introducing the particulate solid material for creating in the chamber a vortex where the particulate material undergoes comminution in the flow of the working fluid, and control of uniformity of the milling and dimensions of the particles therein by deliberately accelerating or retarding discharge from the chamber of the particles moving in the vortex close to the inner walls of the chamber by the mechanical elements provided in the chamber and adapted to interact with such particles.